371
Views
10
CrossRef citations to date
0
Altmetric
Articles

The impact of anxiety and depression in the quality of life and psychological well-being of Greek hematological cancer patients on chemotherapy

, ORCID Icon, , &
Pages 201-213 | Received 12 Mar 2019, Accepted 04 Nov 2019, Published online: 28 Nov 2019

References

  • Abuelgasim, K. A., Ahmed, G. Y., Alqahtani, J. A., Alayed, A. M., Alaskar, A. S., & Malik, M. A. (2016). Depression and anxiety in patients with haematological malignancies, prevalence, and associated factors. Saudi Medical Journal, 37(8), 877–881.
  • Akechi, T., Akazawa, T., Komori, Y., Morita, T., Otani, H., Shinjo, T., … Kobayashi, M. (2012). Dignity therapy: Preliminary cross-cultural findings regarding implementation among Japanese advanced cancer patients. Palliative Medicine, 26(5), 768–769.
  • Annunziata, M. A., Muzzatti, B., Mella, S., & Bidoli, E. (2013). Fatigue, quality of life, and mood states during chemotherapy in Italian cancer patients. Tumori, 99(1), 28–33.
  • Boulanger, L., Zhao, Y., Bao, Y., & Russell, M. W. (2009). A retrospective study on the impact of comorbid depression or anxiety on healthcare resource use and costs among diabetic neuropathy patients. BMC Health Services Research, 9, 1–11.
  • Caprara, G. V., Castellani, V., Alessandri, G., Mazzuca, F., La Torre, M., Barbaranelli, C., … Ziparo, V. (2016). Being positive despite illness: The contribution of positivity to the quality of life of cancer patients. Psychology and Health, 31(5), 524–534.
  • Charalambous, A., Kaite, C. P., Charalambous, M., Tistsi, T., & Kouta, C. (2017). The effects on anxiety and quality of life of breast cancer patients following completion of the first cycle of chemotherapy. SAGE Open Medicine, 5, 205031211771750.
  • Chen, Q., Li, S., Wang, M., Liu, L., & Chen, G. (2018). Health-related quality of life among women breast cancer patients in Eastern China. BioMed Research International, 2018. doi:10.1155/2018/1452635
  • Cheung, Y. T., Shwe, M., Chui, W. K., Chay, W. Y., Ang, S. F., Dent, R. A., … Chan, A. (2012). Effects of chemotherapy and psychosocial distress on perceived cognitive disturbances in Asian breast cancer patients. Annals of Pharmacotherapy, 46(12), 1645–1655.
  • Dauchy, S., Dolbeaut, S., & Reich, M. (2013). Depression in cancer patients. European Journal of Cancer Supplements, 11(2), 205–215.
  • De la Fuente, R., Parra, A., & Sánchez-Queija, I. (2017). Psychometric properties of the flourishing scale and measurement invariance between two samples of Spanish University students. Evaluation and the Health Professions, 40(4), 409–424.
  • Deci, E. L., & Ryan, R. M. (2008). Hedonia, eudaimonia, and well-being: An introduction. Journal of Happiness Studies, 9(1), 1–11.
  • Fischer, D. J., Villines, D., Kim, Y. O., Epstein, J. B., & Wilkie, D. J. (2010). Anxiety, depression, and pain: Differences by primary cancer. Supportive Care in Cancer, 18(7), 801–810.
  • Graça Pereira, M., Figueiredo, A. P., & Fincham, F. D. (2012). Anxiety, depression, traumatic stress and quality of life in colorectal cancer after different treatments: A study with Portuguese patients and their partners. European Journal of Oncology Nursing, 16(3), 227–232.
  • Grotmol, K. S., Lie, H. C., Hjermstad, M. J., Aass, N., Currow, D., Kaasa, S., … Loge, J. H. (2017). Depression—a major contributor to poor quality of life in patients with advanced cancer. Journal of Pain and Symptom Management, 54(6), 889–897.
  • Hinz, A., Singer, S., & Brähler, E. (2014). European reference values for the quality of life questionnaire EORTC QLQ-C30: Results of a German investigation and a summarizing analysis of six European general population normative studies. Acta Oncologica, 53(7), 958–965.
  • Kafetsios, K., & Karaolanis, S. (2016). On social status, cultural orientation and well-being: A comparison between urban and rural areas in Greece. In Proceedings of the 1st International Conference in the Social Sciences, University of Crete, Rehtymno.
  • Kitamura, Y., Hattori, S., Yoneda, S., Watanabe, S., Kanemoto, E., Sugimoto, M., … Sendo, T. (2015). Doxorubicin and cyclophosphamide treatment produces anxiety-like behavior and spatial cognition impairment in rats: Possible involvement of hippocampal neurogenesis via brain-derived neurotrophic factor and cyclin D1 regulation. Behavioural Brain Research, 292, 184–193.
  • Kornblith, A. B., Powell, M., Regan, M. M., Bennett, S., Krasner, C., Moy, B., & Winer, E. (2007). Long-term psychosocial adjustment of older vs younger survivors of breast and endometrial cancer. Psychooncology, 16(10). doi:895–903.10.1002/pon.1146.
  • Lienert, J., Marcum, C. S., Finney, J., Reed-Tsochas, F., & Koehly, L. (2017). Social influence on 5-year survival in a longitudinal chemotherapy ward co-presence network. Network Science, 5(3), 308–327.
  • Machado-Alba, J. E., Medina-Morales, D. A., & Echeverri-Cataño, L. F. (2016). Evaluation of the quality of life of patients with diabetes mellitus treated with conventional or analogue insulins. Diabetes Research and Clinical Practice, 116(14), 237–243.
  • McMullen, M., Lau, P. K. H., Taylor, S., McTigue, J., Cook, A., Bamblett, M., … Johnson, C. E. (2018). Factors associated with psychological distress amongst outpatient chemotherapy patients: An analysis of depression, anxiety and stress using the DASS-21. Applied Nursing Research, 40(December2017), 45–50.
  • Michopoulos, I., Douzenis, A., Kalkavoura, C., Christodoulou, C., Michalopoulou, P., Kalemi, G., … Lykouras, L. (2008). Hospital anxiety and depression scale (HADS): Validation in a Greek general hospital sample. Annals of General Psychiatry, 7(4).
  • Mystakidou, K., Tsilika, E., Parpa, E., Kalaidopoulou, O., Smyrniotis, V., & Vlahos, L. (2001). The EORTC core quality of life questionnaire (QLQ-C30, version 3.0) In terminally ill cancer patients under palliative care: Validity and reliability in a hellenic sample. International Journal of Cancer, 94(1), 135–139.
  • Nanni, M. G., Caruso, R., Travado, L., Ventura, C., Palma, A., Berardi, A. M., … Grassi, L. (2018). Relationship of demoralization with anxiety, depression, and quality of life: A Southern European study of Italian and Portuguese cancer patients. Psycho-Oncology, 27(11), 2616–2622.
  • Nho, J. H., Reul Kim, S., & Nam, J. H. (2017). Symptom clustering and quality of life in patients with ovarian cancer undergoing chemotherapy. European Journal of Oncology Nursing, 30, 8–14.
  • Nikendei, C., Terhoeven, V., Ehrenthal, J. C., Maatouk, I., Wild, B., Herzog, W., & Friederich, H. C. (2018). Depression profile in cancer patients and patients without a chronic somatic disease. Psycho-Oncology, 27(1), 83–90.
  • Schneider, A., Kotronoulas, G., Papadopoulou, C., McCann, L., Miller, M., McBride, J., … Maguire, R. (2016). Trajectories and predictors of state and trait anxiety in patients receiving chemotherapy for breast and colorectal cancer: Results from a longitudinal study. European Journal of Oncology Nursing, 24, 1–7.
  • Schotanus-Dijkstra, M., Drossaert, C. H. C., Pieterse, M. E., Boon, B., Walburg, J. A., & Bohlmeijer, E. T. (2017). An early intervention to promote well-being and flourishing and reduce anxiety and depression: A randomized controlled trial. Internet Interventions, 9(April2016), 15–24.
  • Scott, N. W., & Fayers, P. M. A. N. K. (2008). EORTC QLQ-C30 Reference Values.
  • Shin, W., Kyoung, Song, S., Jung, S. Y., Lee, E., Kim, Z., Moon, H. G., … Lee, J. E. (2017). The association between physical activity and health-related quality of life among breast cancer survivors. Health and Quality of Life Outcomes, 15(1), 1–10.
  • Tang, F., Wang, J., Tang, Z., Kang, M., Deng, Q., Yu, J., & Li, D. (2016). Quality of life and its association with physical activity among different types of cancer survivors. PLoS ONE, 11(11), 1–14.
  • Van Esch, L., Roukema, J. A., Van Der Steeg, A. F. W., & De Vries, J. (2011). Trait anxiety predicts disease-specific health status in early-stage breast cancer patients. Quality of Life Research, 20(6), 865–873.
  • Yasin, Y. M., & Al-Hamad, A. (2015). Anxiety and depression as key determinants of cancer related fatigue among patients receiving chemotherapy. European Scientific Journal, 11(33), 39–53. Retrieved from http://go.galegroup.com.ezproxy.lib.usf.edu/ps/i.do?id=GALE%7CA437556815&sid=googleScholar&v=2.1&it=r&linkaccess=fulltext&issn=18577881&p=AONE&sw=w

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.